New CPT Codes Approved for Sleep Apnea Treatment
The American Medical Association has established new coding for hypoglossal nerve stimulation to streamline billing.
Updated on Oct. 1, 2026 in Sleep Disorders
Live Poll
Should medical device companies prioritize creating new coding standards to simplify hospital and physician administrative tasks?
The American Medical Association CPT Editorial Panel has approved new Category I CPT codes for hypoglossal nerve stimulation, including systems like the Inspire V. This development aims to establish a consistent path for medical coding and insurance reimbursement for patients.
Why it matters
Standardizing these codes provides a clear pathway for reimbursement, which may improve access to obstructive sleep apnea therapies. The initiative seeks to bring uniform structure to how this specialized treatment is billed across the U.S. healthcare system.
The approval covers over 10 years of clinical experience and therapy used by more than 140,000 patients. The new Category I CPT codes are currently awaiting specific valuation by the Centers for Medicare & Medicaid Services.
The players
American Medical Association
A professional association and national representative body for physicians that maintains the CPT coding system.
Centers for Medicare & Medicaid Services
A federal agency that administers Medicare and Medicaid and sets reimbursement values for medical procedures.
Inspire Medical Systems
A medical technology company based in Minneapolis that develops nerve stimulation therapies for obstructive sleep apnea.
The details
Hypoglossal nerve stimulation works by using an implanted device to stimulate the nerve that controls tongue movement, helping to keep the airway open during sleep. The transition to Category I status requires the Centers for Medicare & Medicaid Services to evaluate physician work, time, and practice expenses. Specialty societies will survey their members to provide recommendations to the RUC to assist in these upcoming valuation efforts.
Timeline
July 2027: CMS is expected to publish proposed valuations for the new codes.
November 2027: CMS will publish the final valuations for the CPT codes.
January 1, 2028: The new Category I CPT codes will take effect.
Health Landscape
This move marks a shift in how hypoglossal nerve stimulation is recognized within the formal medical coding architecture. It follows the established RUC valuation process used to integrate new therapeutic technologies into standardized national reimbursement schedules.
If you are currently managing obstructive sleep apnea with nerve stimulation, this change may affect how your care is processed by insurance providers in the future. It is worth discussing with your doctor how these coding updates might influence billing and coverage for your treatment plan.
The takeaway
The move toward standardized coding is a significant step in the long-term adoption of nerve stimulation for sleep apnea. Patients should track how their insurance coverage evolves as these official codes are implemented in 2028.
What happens next
The Centers for Medicare & Medicaid Services is scheduled to publish proposed code valuations in July 2027, followed by final valuations in November 2027, before the new codes officially take effect on January 1, 2028.
Further reading
Learn more about the latest developments in managing chronic conditions in our Sleep Disorders section.
More information
For more information on the technology, visit Inspire Medical Systems company information.
Live Poll
Should medical device companies prioritize creating new coding standards to simplify hospital and physician administrative tasks?
